Safety and Effectiveness of OBG vs.a Bandage Contact Lens for Large Corneal Epithelial Defects in Patients Post-PRK.
A Randomized, Masked (Reading Center), Prospective Pilot Study of the Safety and Effectiveness of the EyeGate Ocular Bandage Gel, a 0.75% Crosslinked Hyaluronic Acid Applied Topically, Versus a Bandage Contact Lens for Acceleration of Re-epithelialization of Large Corneal Epithelial Defects in Patients Having Undergone Photorefractive Keratectomy (PRK).
Sponsor: Eyegate Pharmaceuticals, Inc.
This NA trial investigates Corneal Epithelial Wound and is currently completed. Eyegate Pharmaceuticals, Inc. leads this study, which shows 7 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Feb 2019 — Jan 2021 [monthly]
Completed NA
Status: Recruiting → Completed · Phase: PHASE1_PHASE2 → NA
-
Oct 2018 — Feb 2019 [monthly]
Recruiting PHASE1_PHASE2
Status: Not Yet Recruiting → Recruiting
▶ Show 2 earlier versions
-
Jun 2018 — Oct 2018 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Jun 2017 — Jun 2018 [monthly]
Not Yet Recruiting PHASE1_PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Eyegate Pharmaceuticals, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .